How the interaction occurs:
Some medicines may slow down how quickly your body processes rivaroxaban.
What might happen:
The amount of rivaroxaban in your blood may increase, which may increase your risk of bleeding, including bleeding from your gums, nosebleeds, unusual bruising, or dark stools.
What you should do about this interaction:
Let your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together. If you have any signs of bleeding, such as bleeding from your gums, nosebleeds, unusual bruising, or dark stools, contact your doctor right away.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Xarelto (rivaroxaban) US prescribing information. Janssen Pharmaceuticals, Inc. March, 2014.
2.Xarelto (rivaroxaban) UK summary of product characteristics. Bayer Schering Pharma September, 2008.
3.Xarelto (rivaroxaban) Canadian prescribing information. Bayer September 10, 2008.
4.US Food and Drug Administration (FDA). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/D rugInteractionsLabeling/ucm093664.htm. Updated 08/05/2011.
5.This information is based on or an extract from the UW Metabolism and Transport Drug Interaction Database (DIDB) Platform, Copyright University of Washington 1999-2014..